Sharon Begley reports on a study published in the American Journal of Public Health that she says “doesn’t inspire confidence that doctors are following evidence-based practices and putting their patients’ welfare first.” Excerpt:
“In a nutshell: a significant percentage of elderly women with severe dementia are getting screened. Such women have an average life expectancy of only 3.3 years. Yet science-based guidelines from the American Cancer Society and other experts say that women with a life expectancy of less than five years should not be screened (because any cancer that’s found will not grow fast enough to cut into her remaining years). Even more disturbing, if an elderly woman with severe dementia is also married and with a net worth of $100,000 or more, she is more than twice as likely to get these inappropriate mammograms as her poorer peers.”
Opinions on other issues in news, journals, PR, advertising, marketing
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments (4)
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
AlanS
January 20, 2010 at 3:19 pmThe fact that doctors are not following evidence-based practices isn’t news.
Translation clinical research into medical practice is a huge problem that has been written about by lots of people over many years. Getting physicians to implement even simple, cheap effective practices that are backed by good evidence is often hard. See for example: Lenfant, Claude. 2003. “Shattuck lecture–clinical research to clinical practice–lost in translation?.” The New England Journal of Medicine 349:868-74.
All the recent fuss over the USPSTF Guidelines is all the the more amusing in this context. Most primary docs will tell you that the USPSTF Guidelines are the gold standard but many of them aren’t aware of many of the guidelines issued by the USPSTF or certainly don’t follow them. See for example, work on cervical cancer screening e.g. Sirovich, Brenda E, and H Gilbert Welch. 2004. “Cervical cancer screening among women without a cervix.” JAMA: The Journal of the American Medical Association 291:2990-3.
Here’s their conclusion: “Many US women are undergoing Pap smear screening even though they are not at risk of cervical cancer. The US Preventive Services Task Force recommendations either have not been heard or have been ignored.”
Rose Hoban
January 22, 2010 at 11:10 amWhat’s most amazing to me about this article are the comments below it. Based on them, I’d say that clearly, we in the media have NOT done a good job at conveying information about risk, assessing personal risk, and assessing the usefulness or futility of various treatments.
We also haven’t made the point that someone’s gonna have to pay for all that treatment – especially in an atmosphere where people don’t like ‘taxes,’ that they don’t understand that our health care system is full of hidden costs that effectively ARE taxes on the rest of us.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like